MET amplification increases the metastatic spread of EGFR-mutated NSCLC

Simon Baldacci1, Zoulika Kherrouche2, Vincent Cockenpot3

  • 1Thoracic Oncology Department, CHU Lille, Siric OncoLille, F-59000, Lille, France; Univ Lille, Lille, France; Univ. Lille, CNRS, Institut Pasteur de Lille, UMR 8161 - M3T - Mechanisms of Tumorigenesis and Targeted Therapies, F-59000, Lille, France.

Abstract

Insights

MET amplification in EGFR-mutated non-small cell lung cancer (NSCLC) drives aggressive tumor growth and metastasis. Targeting MET can reverse this phenotype, suggesting new therapeutic strategies for resistant lung cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • Acquired resistance to EGFR tyrosine kinase inhibitors (EGFR-TKI) in metastatic EGFR-mutated non-small cell lung cancer (NSCLC) occurs in 5-20% of cases.
  • MET amplification is a known mechanism of acquired resistance to EGFR-TKI therapy.
  • The impact of MET amplification on tumor and patient phenotype is not well understood.

Purpose of the Study:

  • To investigate the in vitro and in vivo effects of MET amplification on the biological properties of EGFR-mutated NSCLC cells.
  • To evaluate the clinical significance of MET amplification in EGFR-mutated NSCLC patients progressing on EGFR-TKI therapy.

Main Methods:

  • In vitro studies using the HCC827 cell line (EGFR-mutated NSCLC) to assess the impact of MET amplification on proliferation, anchorage-independent growth, anoikis resistance, migration, and epithelial-to-mesenchymal transition.
  • In vivo studies to evaluate tumor growth and metastatic spread in a xenograft model.
  • Clinical analysis of EGFR-mutated NSCLC patients with MET amplification or high MET overexpression on re-biopsy after EGFR-TKI progression.

Main Results:

  • MET amplification significantly enhanced proliferation, anchorage-independent growth, anoikis resistance, migration, and induced epithelial-to-mesenchymal transition in vitro.
  • In vivo, MET amplification led to increased tumor growth and metastatic spread.
  • MET-TKI treatment reversed the aggressive phenotype induced by MET amplification.
  • Patients with MET amplification showed a shorter time to new metastases after EGFR-TKI progression compared to those with high MET overexpression without amplification.

Conclusions:

  • MET amplification promotes metastatic spread in EGFR-mutated NSCLC, even with an existing driver mutation.
  • These findings highlight the need for therapeutic strategies to prevent or target MET amplification in NSCLC.
  • Targeting MET signaling is a promising approach for overcoming acquired resistance to EGFR-TKI therapy.

Related Concept Videos

Mutations01:39

Mutations

Overview
94.5K
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
44.5K
Spreading of Chromatin Modifications02:25

Spreading of Chromatin Modifications

The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
9.5K
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.9K
Mutation, Gene Flow, and Genetic Drift01:09

Mutation, Gene Flow, and Genetic Drift

In a population that is not at Hardy-Weinberg equilibrium, the frequency of alleles changes over time. Therefore, any deviations from the five conditions of Hardy-Weinberg equilibrium can alter the genetic variation of a given population. Conditions that change the genetic variability of a population include mutations, natural selection, non-random mating, gene flow, and genetic drift (small population size).
64.3K
Increasing Function01:18

Increasing Function

An increasing function exhibits a rise in output values as input values increase. This behavior is depicted graphically as a curve or line that slopes upward from left to right. Such a function satisfies the condition that if x1 < x2, then f(x1) < f(x2), indicating that the function values grow with increasing inputs. This concept is fundamental in understanding growth trends across various domains, such as population dynamics, financial investments, or resource consumption.The...
394